Enveric Biosciences Announces Patent Issuance

Core Viewpoint - Enveric Biosciences has announced the issuance of a new U.S. patent for novel neuroplastogenic small-molecule therapeutics aimed at treating psychiatric and neurological disorders [1] Company Summary - Enveric Biosciences is a biotechnology company focused on developing innovative therapeutics for psychiatric and neurological conditions [1] - The newly issued patent, U.S. Patent No. 12,492,179, covers compositions and treatment methods for substituted ethylamine fused heterocyclic mescaline derivatives [1]